Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Ever since the early 1960s foetal cardiotocography (CTG) has been widely utilised across the globe as a means of intrapartum foetal well-being surveillance. A Cochrane Collaboration review has shown that utilisation of intrapartum CTG reduces incidence of newborn seizures. This in itself is an important outcome as most seizures were hypoxic ischemic and as such had a guarded long-term outcome.1 CTG has not shown clear benefit in reducing cerebral palsy, perinatal death or other labour complications.2 Moreover it has been speculated that CTG use has increased instrumental delivery and Caesarean section rates, due to the high false positive rate and poor positive predictive value of CTG for intrapartum hypoxia.3 In an attempt to reduce unnecessary over-intervention, the concept …
Disclaimer Dr C.C.Lees is supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.
Competing interests None declared.
Provenance and peer review Commissioned; internally peer reviewed.